![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Microbix’s Quality Assessment Products for COVID-19 Tests Get CE Mark
Microbix’s Quality Assessment Products for COVID-19 Tests Get CE Mark
June 9, 2020
Microbix Biosystems’ quality assessment products (QAPs) for COVID-19 real-time polymerase chain reaction (PCR) tests have attained the CE mark.
The products run alongside patient samples during COVID-19 testing to confirm that the test results are reliable — typically at a rate of one QAP per 100 tests.
Microbix said it will immediately begin providing the products to clinical laboratories across the European Union.
Upcoming Events
-
21Oct